Inhibitory Effect of r-Hirudin Variant III on Streptozotocin-Induced Diabetic Cataracts in Rats
Figure 1
Two weeks after diabetic modeling by STZ injection, the onset of diabetic cataracts in rats before rHV3 eye drops administration. (a): normal control (group A); (b): diabetic cataracts to be untreated (group B); (c): diabetic cataracts to be treated with 50 μL (one drop) of 0.053 μg/μL pirenoxine sodium eye drops each time (group F); (d), (e), and (f): diabetic cataracts to be treated with 50 μL (one drop) of 0.5, 1, 2 ATU/μL rHV3 eye drops each time, respectively (groups C, D, E).